Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

UPM-Kymmene Corporation: Managers’ Transactions (Oudeman)

UPM-Kymmene Corporation       Managers’ Transactions             12 February 2021 at 14:30 EET UPM-Kymmene Corporation: Managers’ Transactions (Oudeman)  UPM-Kymmene Corporation has on 12 February 2021 received the following notification:    Person subject to the notification requirementName: Oudeman, MarjanPosition: Member of the BoardIssuer: UPM-Kymmene CorporationLEI: 213800EC6PW5VU4J9U64 Notification type: INITIAL NOTIFICATION____________________________________________ Transaction date: 2021-02-12Venue: NASDAQ HELSINKI LTD (XHEL)Instrument type: SHAREISIN:

Nectarine Health initiates test phase ahead of US launch

Brighter's subsidiary Nectarine Health, which has developed a remote monitoring solution using AI technology to give seniors the confidence to live independently in their own home for longer, is now initiating a test phase with c. 50 users as part of its planned launch in the US. The test phase will run through the spring and is expected to transfer into the commercial phase during the second half of 2021. “The US is the primary market for the launch of our service and we are excited to be making steady progress towards a potential commercialization of our home care product later this

CORRECTION: PROVENTUS CAPITAL PARTNERS IV ISSUES NEW DEBENTURES

The date of the capital increase was incorrectly stated to be 12 February but the correct date is 26 February.PRESS RELEASE Proventus Capital Partners IV AB (publ) today announces that on 26 February 2021, the company will increase its contributed capital by EUR 15.5 million through the issuance of 154,240 series A1 participation loan debentures at a price of EUR 100 each and by an equity contribution of EUR 0.06 million. The new debentures will be eligible for coupon payments from the second quarter 2021. Including the newly issued debentures, Proventus Capital Partners IV’s

CORRECTION: PROVENTUS CAPITAL PARTNERS IV B ISSUES NEW DEBENTURES

The date of the capital increase was incorrectly stated to be 12 February but the correct date is 26 February.PRESS RELEASE Proventus Capital Partners IV B AB (publ) today announces that on 26 February 2021, the company will increase its contributed capital by EUR 49.3 million through the issuance of 216,400 series A1 and 20,000 series A2 participation loan debentures at a price of EUR 100 each and 25,500 series B participation loan debentures at a price of EUR 1,000 each and by an equity contribution of EUR 0.18 million. The new debentures will be eligible for coupon payments from

Notice of Extraordinary General Meeting of myFC Holding AB (publ)

The shareholders in myFC Holding AB (publ), org. No. 556942-1612 (the “Company”), are hereby summoned to an Extraordinary General Meeting on Wednesday, March 3, 2021 at 10:00 in the company's premises, Saltmätargatan 8A 2nd floor, 113 59 Stockholm.Right to participate In order to participate in the Extraordinary General Meeting, shareholders must be entered in the share register kept by Euroclear Sweden AB on Tuesday, February 23, 2021. Furthermore, shareholders who wish to attend the Extraordinary General Meeting must notify the company no later than Thursday, February 25, 2021.

Everysport Media Group: Notice to attend extraordinary general meeting

The shareholders of Everysport Media Group AB (publ), are hereby invited to attend the extraordinary general meeting, to be held on Wednesday 17 March 2021. Due to the COVID-19 pandemic, the general meeting will be carried out only through postal voting pursuant to temporary legislation. It will not be possible for shareholders to attend the general meeting in person or by proxy. Right to attend Shareholders who wish to participate in the general meeting shall: · be entered as shareholders in the share register maintained by Euroclear Sweden AB (”Euroclear”) on Tuesday 9

Year-end report 2020

Fourth quarter 2020   · Net sales increased 63.5% to SEK 340.4 (208.2) million. · Product margin increased 1.6 pp. to 85.7% (84.1%). · Operating profit (EBIT) amounted to SEK 61.2 (35.5) million, corresponding to an operating margin of 18.0% (17.1%). · Adjusted EBITA amounted to SEK 93.2 (47.3) million, corresponding to an adjusted EBITA margin of 27.4% (22.7%) or a 4.7 pp. increase vs. the prior year. · Cash flow from operating activities amounted to SEK 139.9 (61.5) million. · Net profit amounted to SEK 36.7 (23.9) million, an increase of 53.6% vs. the prior year. ·

New long-term incentive plan based on performance, share value and growth established for Raute's senior management and selected key persons

RAUTE CORPORATION STOCK EXCHANGE RELEASE XX FEBRUARY 2021 at 1:45 p.m.   NEW LONG-TERM INCENTIVE PLAN BASED ON PERFORMANCE, SHARE VALUE AND GROWTH ESTABLISHED FOR RAUTE’S SENIOR MANAGEMENT AND SELECTED KEY PERSONS Raute Corporation’s Board of Directors has decided on the commencement of a new long-term incentive plan (LTI 2021–2023) for the Group’s senior management and selected key persons. The new LTI plan is based on performance, share value and growth. The purpose of the plan is to align the objectives of the owners and management in order to develop the company’s value for the

Studsvik’s Interim Report for the Fourth Quarter 2020

· Sales in the fourth quarter increased by 8 per cent in local currency and amounted to SEK 213.5 (202.6) million. · Operating profit was SEK 9.8 (20.4) million. · The free cash flow improved to SEK 39.7 (7.2) million. · The Board of Directors proposes a dividend of SEK 1 per share. · The Annual General Meeting is postponed to June 23, 2021, to increase the chances of physical attendance.  Oct-Dec Oct-Dec Full year Full year 2019 2020 2019 2020Sales, SEK million 213.5 202.

Invitation to webcast for the presentation of Formpipe’s fourth quarter and full year 2020 results

Formpipe’s fourth quarter and full year 2020 results will be published on Tuesday, February 16, 2021, at 08:45 CET. The same day at 01.00-02.00 PM CET; analysts, investors, media and other interested parties are invited to attend a webcast where Formpipe’s CEO, Christian Sundin, will comment on the published report and answer questions. The presentation and question & answers will be given in English. How to participate in the webcast Link to register for the event: https://www.lyyti.in/LIVE_Q_Formpipe_Software__Feb_16th_0854 Live broadcast of the event will be available

SimCorp A/S – Announcement of Managers’ Transactions

Announcement and public disclosure of transactions in SimCorp A/S shares by persons discharging managerial responsibilities and persons closely associated with them 1. Details of the person with managerial responsibilities/person closely associateda) Name Klaus Holse2. Reason for the notificationa) Position/status Chief Executive Officerb) Initial Initial notification notification/Amendment3. Details of the issuer, emission allowance market participant, auction platform,

DDM provides business update with record collections and cash EBITDA

DDM Holding AG (First North Growth Market: DDM) is publishing the following business update for the full year 2020. Record net collections of above EUR 110 million and cash EBITDA of about EUR 100 million. Strong capital position with an equity ratio in the DDM Debt Group of about 30%. Estimated Remaining Collections (120 months) at 31 December 2020 of over EUR 250 million. The majority of the ERC is secured and is expected to be received in the next three years. Cash of EUR 31 million and net debt has decreased by 34% compared to end of 2019 standing at EUR 90 million in the

DDM Debt provides business update with record collections and cash EBITDA

DDM Debt AB (publ) (Nasdaq Stockholm: DDM2) ("DDM Debt") is publishing the following business update for the full year 2020. Record net collections of above EUR 110 million and cash EBITDA of about EUR 100 million. Strong capital position with an equity ratio in the DDM Debt Group of about 30%. Estimated Remaining Collections (120 months) at 31 December 2020 of over EUR 250 million. The majority of the ERC is secured and is expected to be received in the next three years. Cash of EUR 31 million and net debt has decreased by 34% compared to end of 2019 standing at EUR 90 million

Invitation to Q4 2020 webcast

Zalaris ASA will release its fourth quarter 2020 results on Friday 19 February 2021.Zalaris will host a webcast for all shareholders and interested parties on 19 February at 08:30 CET. There will be a Q&A session following the management presentation. Link to webcast will be available on ir.zalaris.com. Contact: Gunnar Manum, CFOMobil: +47 95 17 91 90 This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

AcouSort secures technology rights from DTU

AcouSort AB (“AcouSort”) has signed an agreement obtaining the rights to acquire an invention from the Technical University of Denmark (“DTU”). The invention relates to technology developed by Professor Henrik Bruus at DTU in collaboration with AcouSort and concerns a new and more efficient way of manufacturing AcouSort's acoustic chip.”With this new technology, the future AcouSort separation chips will be easier to manufacture at high volumes in a more cost-effective way. By signing this agreement, we ensure that AcouSort stays in the absolute front line of developing acoustofluidics for

BioStock Studio: Rhovac’s CEO comments on the year-end report

This morning Lund-based drug developer Rhovac released its year-end report. CEO Anders Månsson visited BioStock’s studio to tell us more about the company’s challenges and achievements during 2020 as well as the company’s development plan going forward. Månsson points out that the company has entered 2021 on solid ground and with strong finances, and is now continuing development and recruitment for the ongoing phase IIb study.Watch the full interview at biostock.se: https://www.biostock.se/en/biostock-studio-rhovacs-ceo-comments-on-the-year-end-report/This is a press release from

poLight ASA: Invitation to presentation of Q4 2020 results

poLight ASA will release its fourth quarter 2020 results on Friday 19 February 2021 at 7.00 am CEST. The quarterly report and presentation will be made available on the company's website www.polight.com and www.newsweb.no. CEO Øyvind Isaksen and CFO Alf Henning Bekkevik will present the company's results at 08:30 am CEST through live webcast.Please join the Q4 2020 results webcast by clicking here: https://channel.royalcast.com/landingpage/hegnarmedia/20210219_2/ 

PROVENTUS CAPITAL PARTNERS IV ISSUES NEW DEBENTURES

PRESS RELEASE Proventus Capital Partners IV AB (publ) today announces that on 12 February 2021, the company will increase its contributed capital by EUR 15.5 million through the issuance of 154,240 series A1 participation loan debentures at a price of EUR 100 each and by an equity contribution of EUR 0.06 million. The new debentures will be eligible for coupon payments from the second quarter 2021. Including the newly issued debentures, Proventus Capital Partners IV’s funding amounts to EUR 127.7 million comprised of series A1 participation loan debentures of EUR 127.2 million and

PROVENTUS CAPITAL PARTNERS IV B ISSUES NEW DEBENTURES

PRESS RELEASE Proventus Capital Partners IV B AB (publ) today announces that on 12 February 2021, the company will increase its contributed capital by EUR 49.3 million through the issuance of 216,400 series A1 and 20,000 series A2 participation loan debentures at a price of EUR 100 each and 25,500 series B participation loan debentures at a price of EUR 1,000 each and by an equity contribution of EUR 0.18 million. The new debentures will be eligible for coupon payments from the second quarter 2021. Including the newly issued debentures, Proventus Capital Partners IV B’s funding

Kemira signs a new wind power deal to further reduce GHG emissions

Kemira Oyj, Press Release, February 12, 2021 at 12.00 pm (EET)Kemira signs a new wind power deal to further reduce GHG emissions Kemira and Statkraft have signed a new 10 year power purchase agreement to deliver 43.8 GWh renewable wind energy per year to Kemira’s Finnish sites. The wind power is sourced from the Statkraft’s Harbaksfjellet wind farm in Norway. It is part of Europe’s largest onshore wind project, the Fosen Wind. The first renewable energy purchase agreement between Kemira and Statkraft was signed in 2020. Kemira has set an ambitious climate target of 30% reduction in

First patient treated in TIKOMED’s Phase II study of clinical islet transplantation in patients with brittle diabetes

Viken – 12th February 2021 – TIKOMED, a specialty pharmaceutical company developing an infusion product for improving the outcome in cell therapies, today announced that the first patient has been treated in TIKOMED’s ongoing Phase II international, multicenter study – NNCIT-02.   In the NNCIT-02 study, brittle diabetes patients being transplanted with islets of Langerhans are treated with IBSOLVMIR® which has shown to be able to address the instant blood-mediated inflammatory reaction (IBMIR) occurring as an innate immune reaction to the infusion of transplanted cells. Previously, in

Flowscape wins new contract in USA

A large global consulting company expands its Flowscape installation to a new office in the United States. The customer now use the solution at 21 of their North American offices. The total value of this order is 265,000 SEK the first year and thereafter 70,000 SEK annually.“We have the pleasure of expanding with one of our major customers in North America. The customer sees great value with Flowcape's comprehensive solution and that we fulfill the high demands on functionality, safety and flexibility for their employees. We have continuously adapted our solution to the market's local

EPTI broadens the circle of owners and increases Net Asset Value to over SEK 370M

Stockholm February 12, 2021Despite the current global situation, 2020 was summed up as the best year in the company's history. EPTI has gone from 50 to 100 employees, established itself in two new countries and seen the company's Net Asset Value increase by over 70%.During the winter, the startup factory EPTI brought in new shareholders and partners as part of the strategy to increase exposure to various industries through investors with industry expertise.Among the existing and new shareholders who bought shares are Sebastian Nyaiesh via his family office AllaNova (lawyer, angel

Proposal for election of board members in Nexam Chemcial Holding AB

The Nomination Committee proposes re-election of the Board members Mats Persson, Cecilia Jinert Johansson and Jonna Opitz as regular Board members and election of Martin Roos and Oskar Tuwesson as new regular Board members. Ronnie Törnqvist has declined re-election. Mats Persson is proposed for re-election as Chairman of the Board.Note: This news has been translated from Swedish. The Swedish text shall govern for all purposes and prevail in case of any discrepancy with the English version. For more information, please contact: Mats Persson, Chairman of the Board, +46-706 32 29 23,

There are no items matching the current filter
There are no more items matching the current filter
Back to top